SEVERITY OF ABNORMALITY INFLUENCES DECISION TO TERMINATE PREGNANCIES AFFECTED WITH FETAL NEURAL-TUBE DEFECTS

被引:19
作者
GREVENGOOD, C
SHULMAN, LP
DUNGAN, JS
MARTENS, P
PHILLIPS, OP
EMERSON, DS
FELKER, RE
SIMPSON, JL
ELIAS, S
机构
[1] Departments of Obstetrics and Gynecology, Memphis, TN
[2] Departments of Pediatrics, Memphis, TN
[3] Departments of Radiology, University of Tennessee, Memphis, TN
关键词
ALPHA-FETOPROTEIN; AMNIOCENTESIS; KARYOTYPE; NEURAL TUBE DEFECT; ULTRASONOGRAPHY;
D O I
10.1159/000263947
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
We examined parental decision concerning pregnancy management in women having fetuses with neural tube defects (NTDs) to determine whether severity of defect or method of detection has an impact on the decision making process. Analysis of decisions by 50 women, whose pregnancies were affected by an isolated neural tube defect (NTD) and characterized by a singleton gestation at 24 gestational weeks or less with normal chromosomal complement (46,XX or 46,XY), were assessed. All 23 women carrying fetuses with anencephaly elected to terminate their pregnancies. Of the 27 women carrying fetuses with spina bifida, 21 (77.8%) elected to terminate their pregnancies and 6 (22.2%) elected to continue their pregnancies. Of the 6 pregnancies that were continued, 4 were initially detected by ultrasonography and 2 were ascertained by maternal serum alpha-fetoprotein screening; defects ranged from 2 to 14 vertebral bodies, and none of the defects were craniad to the T9 level. This is in comparison to 5 of the 21 spina bifida cases that were elective pregnancy terminations, which were characterized by fetal lesions craniad to the T9 level. Severity of NTD thus appears to influence the decision to continue or terminate an affected pregnancy.
引用
收藏
页码:273 / 277
页数:5
相关论文
共 14 条
[1]  
Phillips O.P., Elias S., Genetics and epidemiology of neural tube defects, Maternal Serum Screening for Fetal Genetic Disorders, pp. 1-23, (1992)
[2]  
Crane J., Sonographic detection of neural tube defects, Maternal Scrum Screening for Fetal Genetic Disorders, pp. 59-73, (1992)
[3]  
Verp M.S., Bombard A.T., Simpson J.L., Elias S., Parental decision following prenatal diagnosis of fetal chromosomal abnormality, Am J Med Genet, 29, (1988)
[4]  
Shulman L.P., Perspectives on counseling in maternal serum alpha-fetoprotein screening, Maternal Serum Screening for Fetal Genetic Disorders, (1992)
[5]  
Ames M.D., Schut L., Results of treatment of 171 consecutive myelomeningoceles - 1963 to 1968, Pediatrics, 50, (1972)
[6]  
American College of Obstetricians and Gynecologists, Technical bulletin (No 99), (1986)
[7]  
Lorber J., Results of treatment of myelomeningocele, Dev Med Child Neurol, 13, (1971)
[8]  
Pryde P.G., Isada N.B., Hallak M., Johnson M.P., Odgers A.E., Evans M., Determinants of parental decision to continue after non-aneuploid ultrasound-detected fetal abnormalities, Obstet Gynecol, 80, (1992)
[9]  
Vincent V.A., Et al., Pregnancy termination because of chromosome abnormalities: A study of 26, 950 amniocenteses in the southeast, South Med J, 84, (1991)
[10]  
Simpson J.L., Disorders of Sexual Differentiation, pp. 260-322, (1976)